Indrayani Biotech Limited's Company Secretary and Compliance Officer, Ramya Ravi, resigned from her positions effective June 3, 2026, due to professional reasons. The company confirmed that the resignation, which takes effect at the close of business on the said date, was not driven by any material reasons other than those stated in her resignation letter. Indrayani Biotech stated it will make arrangements for a replacement and notify the exchange accordingly in due course.

Resignation Details

The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that the cessation of the officer's role is solely due to professional reasons and no other factors necessitated the departure.

Key Information

Indrayani Biotech Limited will hold its Board meeting to consider the audited financial results for the quarter and year ended March 31, 2026, at a later date due to delays in finalizing accounts. The company was required to submit the standalone and consolidated results by May 30, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The delay impacts the timely disclosure of its annual financial performance to the market.

The company attributed the postponement to the extended time required for consolidating results from its subsidiaries and completing internal and external audit processes. Operational disruptions were also cited as a contributing factor to the delay in preparation. The Board meeting will be scheduled once these processes are concluded, with prior intimation to be provided to the exchanges.

In compliance with regulatory norms, the trading window for dealing in the securities of the company will remain closed for all designated persons. The window will reopen 48 hours after the declaration of the audited financial results for the period ended March 31, 2026. This measure is intended to prevent insider trading during the sensitive period preceding the results announcement.

The intimation was signed by Ramya Ravi, Company Secretary and Compliance Officer. The company has also uploaded the notification to its official website. The delay in results submission is a procedural deviation that the company has communicated to BSE Limited along with the detailed reasons for the deferment.